NCT01499303 - Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG

Fostamatinib

Phase II Trial to evaluate the efficacy of 200mg fostamatinib

Trial Locations (21)

Research Site, Huntsville

Research Site, Denver

Research Site, New Haven

Research Site, Sarasota

Research Site, Atlanta

Research Site, Iowa City

Research Site, Baltimore

Research Site, Boston

Research Site, Rochester

Research Site, St Louis

Research Site, Hackensack

Research Site, New York

Research Site, Rochester

Research Site, Columbus

Research Site, Nashville

Research Site, Houston

Research Site, San Antonio

Research Site, Charlottesville

Research Site, Seattle

Research Site, London

Research Site, Southampton